N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 209/22 (2006.01) A61K 31/405 (2006.01)

Patent

CA 2219115

The invention encompasses the novel compound of Formula (I) as well as a method of treating inflammation and, in particular, cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of inflammation and, in particular, cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).

Nouveaux composé de formule (I) ainsi que méthode de traitement d'inflammations, et en particulier de maladies induites par la cyclooxygénase-2, qui consiste à administrer au patient nécessitant un tel traitement une quantité thérapeutiquement efficace et non toxique d'un composé de formule (I). La présente invention concerne en outre certaines compositions pharmaceutiques pour le traitement des inflammations, en particulier de maladies induites par la cyclooxygénase-2, qui contiennent des composés de formule (I).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1620668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.